FT Vest U.S. Equity Deep Buffer ETF - May (DMAY)
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Equity Deep Buffer ETF - May (CBOE: DMAY).
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Equity Deep Buffer ETF - May (CBOE: DMAY).
On our risk management desk, we look closely at DMAY's structural performance metrics. The 5-year annualized CAGR of 6.45% clearly illustrates how much the upside cap holds back compounding during major bull runs. However, the risk picture remains solid: a beta of 0.46, an 8.1% standard deviation, and a worst 5-year drawdown of just -13.5% prove that the deep buffer protection genuinely works as intended during market corrections.
From a quant and execution standpoint, clients need to be mindful of transaction costs on DMAY. The 0.85% expense ratio sits right at the top tier of what defined-outcome peers charge, and the 0.21% bid-ask spread adds tangible friction if you are buying or selling outside of the fund's annual reset window every May. Execution timing around the reset date is critical to avoid unnecessary slippage.
Looking at the institutional flows for Q2 2026, we see 102 hedge funds and large institutions holding roughly $166M in DMAY. With 26 new positions opened and 36 funds increasing their stakes, total fund ownership climbed by 5.92% to 44.54%. This tells me that institutional appetite for defined-outcome buffers remains robust despite short-term volatility and fluctuations in short interest during May.
Tracking market sentiment across Cboe BZX listings, DMAY trades steadily with a total net asset value hovering near $373 million and daily trading volumes averaging around 20,000 to 22,000 shares. Market prices stay tightly bound to the intraday NAV (DMAYIV), showing that First Trust and Vest Financial maintain effective creation and redemption mechanisms through large block creation units.
Analyzing the recent short interest data for DMAY in May 2026, we noticed a sharp drop of 41.7% down to 90,410 shares by the end of the month, following a brief mid-month surge. With a tiny days-to-cover ratio of about 0.8 days and only 1.4% of shares sold short, speculative short pressure is virtually nonexistent, leaving the ETF to trade cleanly based on its NAV dynamics and options overlay performance.
Explore plasma cleansing, somatic organ swaps, and BCI.